Cannabis Law Report

JULY 24, 2019

Dr Mikael Sodergren , Managing Director and Academic Lead at Sapphire Medical Clinics said: “Medicinal cannabis is a new and exciting field. Dr Mikael Sodergren , Managing Director and Academic Lead at Sapphire Medical Clinics said: “Medicinal cannabis is a new and exciting field.

Epilepsy 40

Epilepsy Medicine Treatment Patients 40

Cannabis Law Report

JUNE 17, 2021

CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) ( “Entheon” ), a biotechnology company focused on developing psychedelic medicines to treat addiction, and Silo Wellness Inc. The more opportunity we can give consumers to access information about themselves in advance of a session, the better.”

Research and Development 75

Research and Development Access Therapy Media 75

Cannabis Law Report

NOVEMBER 9, 2021

Delic” or the “Company”) (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) (Original Source), a leader in new medicines and treatments for a modern world, today announced the official, completed acquisition of Ketamine Wellness Centers Arizona LLC (“KWC”), becoming the largest chain of wellness centers providing ketamine treatments in the U.S.

Treatment 52

Treatment Therapy Media Access 52

Cannabis Law Report

JULY 6, 2021

Professor Johnson also received national media attention for his appearance in the Home Box Office (HBO) original documentary feature, “Addiction”, which won the prestigious Governors Award, a special Emmy Award, from the Academy of Television Arts and Sciences. In 2019, Dr. Johnson received the R. Ben Kaplan, CEO of Ehave, Inc.

Research and Development 97

Research and Development Wellness and Beauty Clinical Trials Therapy 97

Cannabis Law Report

NOVEMBER 18, 2021

The Global Drug Policy Index is composed of 75 policy indicators running across 5 dimensions: the absence of extreme responses, the proportionality of the criminal justice system, health and harm reduction, access to controlled medicines and development. Each country is then given a total score ranging from 0 to 100.

Policy 52

Policy Data Media Access 52

SpeedWeed

MARCH 2, 2021

This southern state has a large population and is embarking upon a limited license program where Georgia’s Access to Medical Cannabis Commission will bestow only six licenses. When we founded Cannabiz Media, our choice was to focus exclusively on cannabis licenses, companies, and contacts. View original article.

Media 52

Media Seed-To-Sale Oil Business 52

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. What if most of it is not based on the level of scientific certainty that cannabis marketing teams and media outlets would have us believe? Recent data suggest the US science knowledge is about the global average.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Kind Meds (Cannabis Education Blog)

FEBRUARY 24, 2022

If you are considering trying legal medicinal or recreational cannabis, it is important to get the facts regarding its potential side effects. was created to perpetuate this stereotype, the federal government had initiated a federal ban, and media portrayal of its so-called ill-effects helped convince many legislators to vote in its favor.

Marijuana 52

Marijuana Research and Development Sleep Strains 52

Leaf Science

JULY 23, 2019

In spite of this, research has shown that THC as much as the other cannabinoids present in cannabis has medicinal value to humans. Medicinal cannabis in the western world. So, it stands to perfect reasoning that consuming cannabis buds, whatever the legal status, can hold health benefits to humans.

Strains 74

Strains Cannabinoids Epilepsy THC 74

Cannabis Law Report

JULY 20, 2019

Marijuana is legal for both recreational and medicinal purposes in California, but it is still illegal under federal law. This is the first time the FDIC has been asked to directly grant or deny a bank access to cannabis banking, according to Findley. This is an increase of 147 depositories from FinCEN’s September 2018 data.

Banking 40

Banking Data Media Business 40

CannaMD

NOVEMBER 6, 2019

Perhaps the commercialization of marijuana and the favorable media coverage surrounding the health effects of marijuana are fostering such a perception. Results further indicate that the presence of medicinal cannabis legislation appears to have no influence over opioid misuse. Marijuana Preferred Over Pain Pills. million to 11.4

Marijuana 87

Marijuana Patients Clinical Trials Data 87

Cannabis Law Report

DECEMBER 14, 2021

(NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), announced today that it is the first company to formulate medical cannabis extract vaporizer pen products in a UK-based manufacturing premises, licensed and approved by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) and Home Office.

Extraction 52

Extraction Patients Medicine Tincture 52

Cannabis Law Report

MAY 6, 2022

Generally, a CBD product seller is expected (or required by law) to provide customers with access to a “certificate of analysis” or “COA” associated with specific products, which COA confirms the levels of CBD in products and upon which customers can rely. Moreover, the FDA has concluded that these Delta-8 THC products are misbranded.

THC 52

THC CBD Media Food 52

Cannabis Law Report

JANUARY 13, 2020

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. 14th at 11:00 a.m. PT (2:00 p.m.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

Cannabis Law Report

SEPTEMBER 24, 2019

T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. These treatments can be prescribed only by specialist doctors in a limited number of circumstances where other medicines have failed. Recreational use of cannabis remains illegal.

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Freedom Leaf

JANUARY 4, 2018

After months of development, my partner and I built and successfully launched the beta for our cannabis data-analytics software, Jade Insights. It’s a software platform that helps cannabis businesses augment their process by providing insights for data-backed decision-making. ” JOHN KAGIA. ” OPHELIA CHONG.

Data 60

Data Policy Media Cannabis 60

Cannabis Law Report

JULY 23, 2022

The scam became apparent after investors were unable to access their accounts on a platform called Juicyfields.io. Since 2020, the company Juicyfields offered a service called “e-growing” where investors could participate in the cultivation, harvest and sale of medicinal cannabis. Frozen accounts. The next big exit scam?

Research and Development 59

Research and Development Media Access Banking 59

SpeedWeed

JULY 30, 2021

In my review of that book for Leafly , I charged Berenson with being a fundamentally dishonest writer, willing to purposefully and consistently distort data and provide false witness so long as it bolsters his central claim that cannabis is incredibly dangerous. So if you’re asking me where to turn for the hard data, I’d say start here.

Marijuana 52

Marijuana History Data Strains 52

Cannabis Law Report

JANUARY 20, 2022

Eleusis pioneers the development of psychedelic drug candidates in the life sciences space, with the goal of transforming psychedelics into broadly accessible medicines. Medicines and Healthcare products Regulatory Agency’s Innovative Licensing and Access Pathway (“ILAP”), offering the potential to accelerate time to market.

Therapy 52

Therapy Research and Development Business Access 52

Cannabis Law Report

OCTOBER 14, 2021

As an organization focused on normalizing and professionalizing the cannabis industry, we sincerely look forward to supporting and expanding upon this research that will continue to help create safe, effective and accessible cannabis products.”. Academic clinical research partnership with Lewis Katz School of Medicine at Temple University.

Research and Development 52

Research and Development Dispensary Seed-To-Sale Cultivation 52

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. Accessed July 25, 2021. Available at: [link] Accessed October 17, 2022.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

JANUARY 27, 2020

In Europe, probably more than in any other part of the world, safety is taken incredibly seriously – and has often been used time and time again to banish non-medicinal products and supplements from the market, irrespective of the benefits they might provide to citizens. Inevitably, this is an area we’re watching very closely.

Safety 59

Safety CBD Food Seed-To-Sale 59

Cannabis Law Report

OCTOBER 14, 2021

As an organization focused on normalizing and professionalizing the cannabis industry, we sincerely look forward to supporting and expanding upon this research that will continue to help create safe, effective and accessible cannabis products.”. Academic clinical research partnership with Lewis Katz School of Medicine at Temple University.

Research and Development 52

Research and Development Dispensary Seed-To-Sale Cultivation 52

MedicalJane

DECEMBER 6, 2017

A 2017 Annals of Internal Medicine review , however, found insufficient evidence to draw any conclusions. From there, access became an issue with only a small amount of dispensaries allowed to operate in the state. ” She went on to note that medical marijuana patients may opt for out-of-state, non-medicinal options instead.

Programs 47

Programs Legislation Patients Education 47

Greenspoon Marder Cannabis Law Group Blog

APRIL 2, 2019

For example, we’re seeking comments, data and information on a variety of topics including: what levels of cannabis and cannabis-derived compounds cause safety concerns; how the mode of delivery (e.g., Selling unapproved products with unsubstantiated therapeutic claims can put patients and consumers at risk.

CBD 40

CBD Research and Development Safety Therapy 40

Cannabis Law Report

JULY 20, 2019

New Jersey recently responded to public demand to revise and expand its medical marijuana program to address issues such as supply scarcity, employment and hiring concerns, and geographic access problems. Ability to provide appropriate research data. MEDIA CONTACT. Criterion 5. Criterion 7.

Law 40

Law Marijuana Education Cultivation 40

Cannabis Law Report

NOVEMBER 24, 2021

Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access.

Research and Development 52

Research and Development Medicine Access Media 52

The Joint Blog

APRIL 30, 2020

With access to data now-a-days such as LinkedIn, company websites and social media, finding information that you can use is not difficult. For example: If you can find the interviewer’s social media profiles and see some picture of their past times that you may have in common, it’s a great way to build rapport.

Indica 36

Indica Sativa Cannabis History 36

The Cannigma

APRIL 8, 2021

Listen & Subscribe: As both a regulated medicine and something people use for wellness and even recreation, the information gaps that exist for cannabis users are unprecedented. The Cannabis Enigma is a co-production of The Cannigma and Americans for Safe Access. I want to treat cannabis like every other medicine.

Medicine 108

Medicine Cannabinoids Cannabis THC 108

Healer

NOVEMBER 15, 2023

In this article, I’ll review what we know and don’t know about the new findings (including some juicy details that didn’t make it to the media reports), compare with some of the previous publications on this topic, and boil it down to what matters for people with cardiovascular disease or cardiovascular risks who want to safely use cannabis.

Data 126

Data Topical Research and Development Conditions 126

Cannabis Law Report

DECEMBER 8, 2019

Editor’s note: The American Journal of Endocannabinoid Medicine (AJEM) is the only printed, peer-reviewed, medical cannabis journal in North America. AJEM’s mission is to create, collect, and disseminate credible cannabis research data. On the one hand, cannabinoids produced by cannabis clearly have medicinal benefits.3-5

Medicine 59

Medicine Research and Development Food Cannabinoids 59

Cannabis Law Report

JULY 9, 2021

European cannabis media outlet Newsweed reports. A recent court ruling , reported by ElDiaro , from the Valencian Community calls into question the opinion of the anti-drug prosecution and the Spanish Medicines Agency. As in France, many Spanish stores sell cannabis flowers with a low THC content. .

CBD 105

CBD Seed-To-Sale Sativa Extraction 105

Veriheal

JANUARY 4, 2021

If you’re familiar with Kratom or cannabis and what their medicinal qualities are, you might be able to lend a helping hand to the man, the US Federal Government, that is. The AHRQ isn’t looking for solid input from the people in regard to the medicinal and therapeutic attributes of either of these two plants.

Chronic Pain 104

Chronic Pain Therapy Cannabinoids Treatment 104

Cannabis Law Report

JULY 12, 2019

As reported in the Guardian, Analytical Cannabis emphasises the importance of this for those suffering from conditions such as chronic pain, epilepsy and neurological and psychiatric disorders who have long been seeking access to what they hope is a transformative medicine. The product must be produced for medicinal use in humans.

Epilepsy 40

Epilepsy Medicine Clinical Trials Chronic Pain 40

The Cannigma

MARCH 2, 2022

Hear the tale of how Anthony came to work in the cannabis space, telling the stories of cannabis brands and making them accessible to non-users. Anthony is the founder of the Trav Media Group. We’ve got a segment with Americans for Safe Access, talking a little bit about regulation and some current affairs. This is a pleasure.

Wellness and Beauty 52

Wellness and Beauty Cannabis Media Patients 52

Cannabis Law Report

NOVEMBER 23, 2019

As of Tuesday, 277 out of the 407 permits involved had not received reinstatement to “active” status, according to state licensing data. The conference call will be accessible on our corporate website at www.investharborside.com and by dialing 888-390-0605 (416-764-8609 for international callers) and providing conference ID 22211128.

Legalization 59

Legalization Retail Research and Development Cultivation 59

Cannabis Law Report

APRIL 8, 2022

as a non-profit organization to fulfill the need to broaden psychedelic research, therapy, and develop legal options for psychedelic medicine. published the first edition of the MAPS Bulletin , titled “ MDMA Can Become a Legal Medicine ,” and the FDA rejected the second MDMA study protocol submitted by MAPS.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52